Alberto Russi

Padova, 35128, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort ("PEMBROREAL" Study).

Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort ("PEMBROREAL" Study).

Journal: Cancers

Published: April 15, 2024

Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting.

Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting.

Journal: The oncologist

Published: April 05, 2023

Analysis of the relation between adverse events and overall survival in patients treated with pembrolizumab as a first-line treatment for metastatic NSCLC.

Analysis of the relation between adverse events and overall survival in patients treated with pembrolizumab as a first-line treatment for metastatic NSCLC.

Journal: BMC pharmacology & toxicology

Published: September 09, 2021

Preparation of intravenous chemotherapy bags: evaluation of a dose banding approach in an Italian oncology hospital.

Preparation of intravenous chemotherapy bags: evaluation of a dose banding approach in an Italian oncology hospital.

Journal: Global & regional health technology assessment

Published: November 03, 2020

Omega-3 for the prevention of cardiovascular diseases: meta-analysis and trial-sequential analysis.

Omega-3 for the prevention of cardiovascular diseases: meta-analysis and trial-sequential analysis.

Journal: European journal of hospital pharmacy : science and practice

Published: January 12, 2020

Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies.

Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies.

Journal: Drug safety

Published: January 17, 2019

Optimization of resources by drug management: A multicentred web-administered study on the use of ipilimumab in Italy.

Optimization of resources by drug management: A multicentred web-administered study on the use of ipilimumab in Italy.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: February 16, 2018

CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL.

CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL.

Journal: International journal of technology assessment in health care

Published: July 14, 2017

Ipilimumab in real-world clinical practice: efficacy and safety data from a multicenter observational study.

Ipilimumab in real-world clinical practice: efficacy and safety data from a multicenter observational study.

Journal: Journal of chemotherapy (Florence, Italy)

Published: April 12, 2017

A survey on patients medication reconciliation process in an oncological hospital.

A survey on patients medication reconciliation process in an oncological hospital.

Journal: Recenti progressi in medicina

Published: April 12, 2017

Is the price of cancer drugs related to the cost of develo-pment and production or to the economic value of their clincal efficacy?

Is the price of cancer drugs related to the cost of develo-pment and production or to the economic value of their clincal efficacy?

Journal: Recenti progressi in medicina

Published: April 20, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026